Pharmafile Logo
Pharmafocus logo
Advanced Search

drugs

Showing 15 posts of 771 posts found.

nerve-cell-2213009_960_720

Another failure in Alzheimer’s creates bleak outlook for treatment

June 12, 2018
Manufacturing and Production, Research and Development Alzheimer's, AstraZeneca, Eli Lilly, biotech, drugs, pharma, pharmaceutical

Finding a treatment for Alzheimer’s disease has been one of the aims of big pharma for last few decades, but …

News
handshake_2

Alexion goes back to roots with Complement deal

June 11, 2018
Manufacturing and Production, Sales and Marketing Alexion, biotech, drugs, pharma, pharmaceutical, soliris

Alexion has made a lot of money from investing in the science behind complement inhibitors – C5 inhibitor, Soliris, has …

News
thumbs_up

AbbVie/Roche gain FDA approval for blockbuster treatment

June 11, 2018
Sales and Marketing AbbVie, Roche, biotech, drugs, pharma, pharmaceutical

AbbVie and Roche have a chalked up a major success, after the FDA gave its approval for Venclexta, in combination …

News
canada_block_001_takeda

Takeda shareholders try to buck Shire deal

June 11, 2018
Sales and Marketing Shire, Takeda, biotech, drugs, pharma, pharmaceutical

A small group of Takeda shareholders have started making a lot of noise over its $62 billion deal for Shire, …

News
astrazeneca_logo_building

EU gives nod to expanded label for AZ’s Tagrisso

June 11, 2018
Sales and Marketing AstraZeneca, Tagrisso, biotech, drugs, pharma, pharmaceutical

AstraZeneca has scored another success with Tagrisso in Europe, by receiving an expanded marketing authorisation for Tagrisso in the first-line …

News
kendall_square_boston

Ipsen set to relocate North American HQ to Boston

June 11, 2018
Medical Communications, Sales and Marketing biotech, drugs, ipsen, pharma, pharmaceutical

Ipsen is set to join the ranks of a number of Boston-based biotechs, by setting up shop in Kendall Square. …

News
p_cagnoni_online

Rubius Therapeutics brings in new CEO

June 11, 2018
Medical Communications, Sales and Marketing Rubius Therapeutics, biotech, drugs, pharma, pharmaceutical

Rubius Therapeutics, a biotech that has ambitions to bring “super blood” to the market, has revealed that it has appointed …

News
top_ten

Top Ten most popular articles on Pharmafile.com this week

June 8, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

With ASCO occurring over the weekend, the headlines this week have been dominated by the news of breaking research that …

News

6.5% pay rise agreed for NHS staff

June 8, 2018
Medical Communications NHS, biotech, drugs, pharma, pharmaceutical

After years of receiving only a 1% annual pay rise, NHS staff have voted to accept a 6.5% pay offer increase …

News
pfizer_chrome_plate

Pfizer successfully appeals 2,600% price hiking case

June 8, 2018
Medical Communications Flynn Pharma, Pfizer, biotech, drugs, pharma, pharmaceutical

Pfizer and co-defendant Flynn Pharma have won their appeal against a £90 million fine imposed on them by the Competition …

News

Bill Gates backed biotech reveals strategy

June 8, 2018
Medical Communications Bill and Melinda Gates Foundation, biotech, drugs, pharma, pharmaceutical

The Bill and Melina Gates Foundation already funnels a large amount of money into aiding public health, particularly by funding …

News
cancer_research_uk

Cancer Research UK unveil new Chief Business Officer

June 8, 2018
Medical Communications Cancer Research UK, biotech, drugs, pharma, pharmaceutical

Cancer Research UK has appointed Tony Hickson to the position of Chief Business Officer. He arrives to the business from …

News
nerves

Parkinson’s disease: A quest for steadier therapies

June 7, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Parkinson's disease, biotech, drugs, pharma, pharmaceutical

The worrying number of deaths associated with Nuplazid has eyes returning to the pipeline for Parkinson’s disease. Anjali Shukla, a …

Feature

J&J looks to trim business with $2.8bn sale

June 7, 2018
Sales and Marketing Johnson & Johnson, biotech, drugs, pharma, pharmaceutical

Johnson & Johnson continues to look at options to slim down its business, after having received an offer from Fortive …

News

Pfizer pumps $600m into venture fund, targeting neuroscience

June 7, 2018
Research and Development, Sales and Marketing Pfizer, biotech, drugs, neuroscience, pharma, pharmaceutical

Pfizer’s move to dump its neuroscience divisions caused serious ripples through the industry, with many wondering whether it heralded an …

News

Latest content

GSK shares data from global shingles survey

December 1, 2023

AbbVie to acquire ImmunoGen for approximately $10.1bn

December 1, 2023

FDA accepts NDA for Karuna’s schizophrenia treatment

November 30, 2023

Vivos Therapeutics gains FDA 510(k) clearance for sleep apnea treatment device

November 30, 2023

Tolremo doses first patient in phase 1 trial for drug to combat transcriptional cancer drug resistance

November 29, 2023